Some studies suggest that markers more specific to NET formation, such as circulating MPO/DNA or NE/DNA complexes, as well as plasma levels of citrullinated histone H3 (H3Cit), are associated with poor prognosis in cancer patients [135]. The gene discussed is MPO; the disease is cancer.